Cefproj-100CV Suspension Dry Syrup is a broad-spectrum antibiotic formulated with Cefpodoxime (100 mg) and Clavulanate (62.50 mg). It is primarily used to treat bacterial infections in children. Cefpodoxime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, leading to bacterial death. Clavulanate is a beta-lactamase inhibitor that enhances the effectiveness of Cefpodoxime by preventing bacterial resistance.
This combination is particularly effective against respiratory tract infections, urinary tract infections (UTIs), ear infections (otitis media), sinusitis, skin infections, and soft tissue infections. It is prescribed for pediatric patients suffering from infections caused by beta-lactamase-producing bacteria, ensuring better treatment outcomes.
Cefproj-100CV Dry Syrup offers quick relief from infections and prevents bacterial growth, reducing the risk of complications. The syrup form makes it easy to administer to children, ensuring better compliance and effective dosing.
For best results, it is recommended to take the medication with food to enhance absorption and reduce the risk of stomach upset. Completing the full course of the antibiotic is essential to prevent bacterial resistance and recurrence of infections.
